| With the rapid development of the pharmaceutical industry and the increasing competition in new drug development,more and more pharmaceutical companies choose to outsource part or all of their R&D production to pharmaceutical R&D service companies in order to improve their own efficiency and reduce R&D costs,therefore,the pharmaceutical R&D service industry has seen unprecedented development and growth.Due to its high R&D costs and high operational risks,the pharmaceutical R&D services industry will face various challenges while opening up good opportunities.Excessive financial risks will affect the healthy development of enterprises,therefore,it is important to evaluate and control the effective financial risks of enterprises.This paper takes K Pharmaceutical R&D Company as the research object.Firstly,it adopts the literature research method to sort out the theories related to financial risks,systematically organizes the research results related to the evaluation and control methods of financial risks at home and abroad,and establishes the research ideas and methods.Then,we used the report analysis method to initially identify the current situation of financial risks in the pharmaceutical R&D service industry in which Company K is located,and then conducted an in-depth analysis of the financial risks faced by Company K in terms of financing risks,investment risks,operational risks and growth risks.Subsequently,the evaluation system was established by selecting risk evaluation indicators through correlation analysis and other means,and the weight of each indicator was determined by the entropy weighting method,combined with the TOPSIS method to quantitatively evaluate the degree of financial risk of Company K.The trend of changes in financial risk of the company in the past five years was obtained,combined with the company’s business development status,as well as investment and financing,corporate mergers and acquisitions,overseas market adjustment and other behaviors,from earnings,debt service,operations,growth We analyzed the changes in financial risks and their causes in detail in the light of the company’s business development,as well as its investment and financing,corporate M&A,overseas market adjustment and other behaviors,from profitability,debt service,operation,growth,cash flow capacity and industry-specific indicators.On this basis,the company proposes risk control recommendations such as broadening corporate financing channels,developing domestic business for small and medium-sized enterprises,improving inventory management,and setting up a special financial risk control team,in order to promote the long-term healthy growth of the company and provide reference for the business development and risk control of enterprises in the same industry.It is expected to promote the long-term healthy growth of the company and provide reference for the business development and risk control of enterprises in the same industry. |
